Adaptimmune Therapeutics Plc (ADAP) Live Share Price, Invest From India

Adaptimmune Therapeutics Plc Stock Performance

as on October 28, 2025 at 6:59 am IST

Day's Low
Day's High
$0.05
Day's Price Range
$0.07
$0.06
16.67%
Downside
16.67%
Upside
52 Week's Low
52 Week's High
$0.04
52-Week Price Range
$0.36
$0.06
32.83%
Downside
496.33%
Upside

Adaptimmune Therapeutics Plc share price movements today

Previous Close: $0.06
Open: $0.07
Volume: 45.5M
Day's Low - High: $0.05 - $0.07
52 Week Low - High: $0.04 - $0.36

Adaptimmune Therapeutics Plc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Adaptimmune Therapeutics Plc Stock Fundamentals & Key Indicators

Check Adaptimmune Therapeutics Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Adaptimmune Therapeutics Plc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adaptimmune Therapeutics Plc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Adaptimmune Therapeutics Plc	BUY	$-	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.3B	116.54%	133.52	8.45%
Beone Medicines Ltd	NA	$32.5B	NA	114.93	5.37%
Vertex Pharmaceuticals Incorporated	BUY	$116.3B	110.08%	29.94	32.94%
Regeneron Pharmaceuticals, Inc.	BUY	$78.0B	54.71%	17.8	31.41%

Analyst Recommendation on Adaptimmune Therapeutics Plc Stock

Based on 13 analysts

BUY

69.23%

Buy

23.08%

Hold

7.69%

Sell

Based on 13 analysts, 69.23% of analysts recommend a 'BUY' rating for Adaptimmune Therapeutics Plc. Average target price of $0.68

Adaptimmune Therapeutics Plc Share Price Target

Get share price movements and forecasts by analysts on Adaptimmune Therapeutics Plc.

What analysts predicted

91.18%UPSIDE

Target Price

$0.68

Current Price

$0.06

Analyzed by

13 Analysts

Target

$0.68

Adaptimmune Therapeutics Plc target price $0.68, a slight upside of 91.18% compared to current price of $0.06. According to 13 analysts rating.

Adaptimmune Therapeutics Plc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	47	5	7	0	5	128	40	3	7	13
Gross Profit	45	2	4	-2	2	125	40	3	6	11
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	1	-21	-45	-48	-48	69	-17	-74	-47	-30
Net Profit Margin	2.18%	-416.94%	-623.05%	-20743.33%	-854.23%	54.22%	-43.07%	-2303.38%	-653.18%	-221.83%

Adaptimmune Therapeutics Plc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	10	14	37	59	1	3	6	27	60	178
Gross Profit	10	14	37	59	-96	-87	-104	-100	50	177
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-21	-71	-70	-95	-137	-130	-158	-165	-113	-70
Net Profit Margin	-201.36%	-504.15%	-185.39%	-160.51%	-12225.04%	-3286.81%	-2570.99%	-609.46%	-188.90%	-39.78%

Global Institutional Holdings in Adaptimmune Therapeutics Plc

Funds	Holdings
EcoR1 Capital, LLC	10.34%
Long Focus Capital Management, LLC	8.96%
Two Seas Capital LP	8.52%
NEA Management Company, LLC	6.44%
Mpm Asset Management, LLC	1.81%

See all

Insights on Adaptimmune Therapeutics Plc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ADAP stock has moved up by 33.1%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 3.22M → 13.67M (in $), with an average increase of 51.3% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -74.21M → -30.34M (in $), with an average increase of 56.4% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 126.6% return, outperforming this stock by 221.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.5% return, outperforming this stock by 152.7%

About Adaptimmune Therapeutics Plc

Adaptimmune Therapeutics PLC is focused on pre-clinical programs, including PRAME and CD70-directed T-cell therapies, and its allogeneic pipeline. PRAME is highly expressed across a range of solid tumors, including ovarian, endometrial, lung and breast cancers. The CD70 program targets the CD70 antigen, which is expressed across a range of hematological malignancies (acute myeloid leukemia and lymphoma) and solid tumors (renal cell carcinoma). It is using TRuC technology to develop a T-cell therapy (ADP-520) against CD70, with membrane bound IL-15 to enhance persistence. ADP-520 is in pre-clinical testing. TRuC technology combines the targeting of CAR-T cells with T-cell TCR signaling.

Organisation	Adaptimmune Therapeutics Plc
E-voting on shares	Click here to vote

FAQs

What is Adaptimmune Therapeutics Plc share price today?

Adaptimmune Therapeutics Plc share price today is $0.06 as on October 28, 2025 at 1:29 am IST at the close of the market. Adaptimmune Therapeutics Plc share today touched a day high of $0.07 and a low of $0.05.

What is the 52 week high and 52 week low for Adaptimmune Therapeutics Plc share?

Adaptimmune Therapeutics Plc share touched a 52 week high of $0.36 on July 24, 2025 and a 52 week low of $0.04 on September 8, 2025. Adaptimmune Therapeutics Plc stock price today i.e. October 28, 2025 at 1:29 am IST is closed at $0.06,which is 83.23% down from its 52 week high and 48.88% up from its 52 week low.

How to invest in Adaptimmune Therapeutics Plc Stock (ADAP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Adaptimmune Therapeutics Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adaptimmune Therapeutics Plc Shares that will get you 25.0000 shares as per Adaptimmune Therapeutics Plc share price of $0.06 per share as on October 28, 2025 at 1:29 am IST.

What is the minimum amount required to buy Adaptimmune Therapeutics Plc Stock (ADAP) from India?

Indian investors can start investing in Adaptimmune Therapeutics Plc (ADAP) shares with as little as ₹93.708 or $1 (as of March 21, 2026 at 5:03 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.08 in Adaptimmune Therapeutics Plc stock (as per the Rupee-Dollar exchange rate as on March 21, 2026 at 5:03 pm IST). Based on Adaptimmune Therapeutics Plc share’s latest price of $0.06 as on October 28, 2025 at 1:29 am IST, you will get 166.6667 shares of Adaptimmune Therapeutics Plc. Learn more about fractional shares .